About the Authors

Rachana D. Shah

Affiliation Division of Pediatric Endocrinology, Children’s Hospital of Philadelphia, Pennsylvania, United States of America

Chenyi Xue

Affiliations Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Medicine, Columbia University, New York, New York, United States of America

Hanrui Zhang

Affiliations Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Medicine, Columbia University, New York, New York, United States of America

Sony Tuteja

Affiliation Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

Mingyao Li

Affiliation Department of Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

Muredach P. Reilly

Affiliations Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Medicine, Columbia University, New York, New York, United States of America

Jane F. Ferguson

jane.f.ferguson@vanderbilt.edu

Affiliation Division of Cardiovascular Medicine, and Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Competing Interests

GlaxoSmithKline provided Lovaza and matching placebo. This commercial funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. None of the authors have any competing interests.

Author Contributions

Conceptualization: RDS MPR JFF. Formal analysis: CX ML JFF. Funding acquisition: MPR. Investigation: RDS HZ ST JFF. Writing – original draft: RDS JFF. Writing – review & editing: RDS CX HZ ST ML MPR JFF.